Skip to Main Content

Medixine in a EUR 5 million Horizon 2020 project that aims to transform care for multimorbid patients

The H2020 project, “A Federated Collaborative Care & Cure Cloud Architecture for Addressing the Needs of Multimorbidity and Managing Poly-pharmacy (C3-Cloud)” tackles the challenges in caring patients with two or more chronic conditions. 12 partners in seven countries have joined forces, and are combining their expertise to improve care provided to elderly patients with multimorbidity.

Patients with multimorbidity have two or more chronic conditions such as diabetes, heart failure, renal failure and depression that make treatment more complicated. Multimorbidity has become more prevalent among the elderly as the population has aged.

Project coordinator, professor Theodoros Arvanitis of the Institute of Digital Healthcare, WMG, University of Warwick said: “The personalised care plans will be developed through systematic and semi-automatic reconciliation of clinical guidelines. The system will incorporate risk prediction and stratification, recommendation reconciliation and poly-pharmacy management. Patients and their next-of-kin are involved through a Patient Empowerment Platform ensuring that their needs are respected in the decision making taking into account preferences and psychosocial aspects.”

Medixine is leading the Patient Empowerment Platform work package in the project. The Patient Empowerment Platform will be based on the Medixine Suite product, which is adapted and enriched in the project. “The project concentrates on providing a patient centric, horizontal service that integrates the complexities of managing multiple conditions into one solution. This is the essence of the Medixine concept and Medixine Suite product so C3-Cloud is an ideal project for Medixine.”, says Tapio Jokinen, CEO of Medixine.

C3-Cloud is funded by Horizon 2020 the biggest EU Research and Innovation programme to date with nearly €80 billion of funding available over seven years (2014 to 2020).

You can read the full project press release here.

 

 

C3

Share in social media: